Dr. Eyal Greenberg
Dr. Eyal Greenberg CEO and Scientific Co-founder of 4C Biomed. Experienced in project management and establishment of high-throughput screening platforms. Broad experience in integrative platforms, including cell biology, genetics, immunology and bioinformatic interfaces.
Prior to establishing 4C Biomed, Eyal Greenberg served as Chief Operating Officer, Researcher and Team Leader at the Ella Lemelbaum Institute for Immuno-Oncology at Sheba Medical Center. Eyal holds a B.Sc. in Life Sciences, M.Sc. in Biotechnology and Ph.D. in Clinical microbiology and Immunology from Tel Aviv University. In addition, Eyal holds a Master of Business Administration from Bar Ilan University. He is the author of multiple peer-reviewed papers and has won several awards.